ARMC7: A Potential Drug Target and Biomarker (G79637)

Target Name: ARMC7

NCBI ID: G79637

ARMC7

ARMC7: A Potential Drug Target and Biomarker

Armadillo repeat containing 7 (ARMC7) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a unique RNA molecule that is composed of a series of ARMADILLO repeat units, which are characterized by a specific arrangement of nucleotides.

ARMC7 is expressed in various tissues and cells throughout the body, including the brain, heart, liver, and pancreas. It has been shown to play a role in several biological processes, including cell signaling, metabolism, and inflammation.

Drug Target Potential

ARMC7 has been identified as a potential drug target due to its unique structure and its involvement in various biological processes. One of the key reasons for its potential as a drug target is its expression in multiple tissues and cells throughout the body, which makes it difficult to target. However, its ARMADILLO repeat structure makes it vulnerable to small molecules that can disrupt its function.

ARMC7 has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that ARMC7 is overexpressed in various types of cancer, including breast, lung, and colon cancer. Additionally, it has been shown to be involved in several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Biomarker Potential

ARMC7 has also been identified as a potential biomarker for several diseases. Its expression has been shown to be elevated in individuals with certain types of cancer, which could make it an useful biomarker for these diseases. Additionally, its expression has been shown to be elevated in individuals with neurodegenerative diseases, which could make it an useful biomarker for these conditions.

Methods

To determine the potential drug target and biomarker properties of ARMC7, several studies have been conducted. These studies have involved a variety of techniques, including RNA sequencing, qRT-PCR, and western blotting.

RNA sequencing (RNA-seq) is a technique that allows researchers to identify the expression of RNA molecules in a given sample. In one study, researchers used RNA-seq to identify the expression of ARMC7 in various tissues and cells. They found that ARMC7 was expressed in all of the tissues and cells tested, including the brain, heart, liver, and pancreas.

qRT-PCR is a technique that allows researchers to measure the expression of specific RNA molecules in a given sample. In another study, researchers used qRT-PCR to measure the expression of ARMC7 in various tissues and cells. They found that ARMC7 was expressed in all of the tissues and cells tested, including the brain, heart, liver, and pancreas.

Western blotting is a technique that allows researchers to measure the expression of specific proteins in a given sample. In a third study, researchers used western blotting to measure the expression of ARMC7 in various tissues and cells. They found that ARMC7 was expressed in all of the tissues and cells tested, including the brain, heart, liver, and pancreas.

Conclusion

ARMC7 is a non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It has been shown to play a role in several biological processes, including cell signaling, metabolism, and inflammation. Its ARMADILLO repeat structure makes it vulnerable to small molecules that can disrupt its function, which makes it a potential drug target. Additionally, its expression has been shown to be elevated in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases, which makes it a potential biomarker. Further research is needed to fully understand the role of ARMC7 in these diseases and to develop effective treatments.

Protein Name: Armadillo Repeat Containing 7

Functions: As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs

The "ARMC7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARMC7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets